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Previous work has shown 50%–75% of HIV-infected individu-als used illicit drugs or had 
heavy alcohol use in the prior year.1,2 
Illicit drug or alcohol use decreas-
es antiretroviral (ARV) adherence, 
increases HIV disease progression, 
and increases HIV transmission 
behaviors.3-6 HIV-infected patients 
with current drug use experience 
decreased health-related quality of 
life.2 
Despite its prevalence and im-
pact, fewer than half of HIV-infected 
patients report discussing substance 
use with their provider.2,7 Provider 
reluctance to screen for substance 
use is unfortunate as patient-
provider discussions are associated 
with decreased use and increased 
receipt of treatment for substance 
use disorders.2,8-12 Treatment im-
proves the health of HIV-infected 
patients through improved ARV ad-
herence, regular primary care visits, 
decreased hospital utilization, and 
improvement of common medical ill-
nesses impacted by substance use 
(eg, liver disease).13-15 
In previous studies, providers re-
ported hesitation over correctly diag-
nosing substance abuse or providing 
resources to substance users.16,17 
Providers also fear alienating their 
patients despite research to the con-
trary. Miller and colleagues found 
that more than 90% of patients 
support their provider screening for 
alcohol use.18 Recent studies identi-
fied providers with positive percep-
tions of their abilities as more likely 
to screen their patients with alcohol 
disorders.19 The quality of patient-
provider communication is different 
between HIV-infected patients with 
problematic alcohol use than those 
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BACKGROUND AND OBJECTIVES: Substance use is a prevalent 
issue in primary care with wide-reaching implications, particularly 
for the care of HIV-infected patients. This analysis identified patient 
and provider characteristics associated with high comfort discuss-
ing substance use in HIV primary care clinics using multivariable 
logistic regression. 
METHODS: A total of 413 patients and 44 providers completed 
surveys on their comfort discussing substance use. Additional in-
dependent variables from surveys included demographics, drug 
and alcohol use, self-efficacy, and activation for patients. Provider-
level data included demographics, training, practice descriptors, 
and stress levels. 
RESULTS: The majority of patients (76%) and providers (73%) re-
ported high comfort. In multivariable analysis, patients with current 
problematic alcohol use or current drug use were half as likely to 
report high comfort compared to their non-substance-using peers. 
Higher patient self-efficacy and high levels of patient activation 
were independently associated with increased odds of high pa-
tient comfort. While provider-level characteristics were not associ-
ated with provider comfort, the types of patients a provider saw 
were. Namely, the proportion of patients on antiretroviral therapy 
was inversely associated with the odds of high provider comfort, 
whereas the proportion of patients with high patient activation was 
positively associated.  
CONCLUSIONS: Patients likely to benefit from a discussion of 
substance use, those with current use, are the least likely to report 
comfort discussing that use. Interventions that increase patient 
activation or self-efficacy may also increase their comfort. This re-
search guides future interventions to increase the prevalence of 
discussions on substance use.
(Fam Med 2013;45(2):109-17.)
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with illicit drug use.19 Thus, provid-
er perception of their own comfort 
and ability to discuss alcohol or drug 
abuse with their patients may be an 
important predictor of patients get-
ting the treatment they need.
In ambulatory care settings, dis-
cussions of substance use are impor-
tant yet often missed opportunities 
to improve the quality of health care. 
There is a paucity of literature on 
comfort when discussing substance 
use from the perspective of either 
the patient or the provider. Intuitive-
ly, high comfort discussing substance 
use would be associated with conver-
sations regarding use, yet there is 
no previous research to support this. 
The purpose of this study was to as-
sess patient and provider comfort 
discussing substance use in a pri-
mary care setting. We chose to con-
duct the study in HIV primary care 
practices where the consequences of 
substance abuse and the potential 
impact of patient-provider substance 
use discussions are great.
Methods 
Study Sample and 
Data Collection
The Enhancing Communication and 
HIV Outcomes (ECHO) study was a 
cross-sectional study that investigat-
ed the impact of patient-provider com-
munication on HIV-related clinical 
outcomes. Study methods have been 
published previously.20 Briefly, pa-
tients and providers were recruited 
from four HIV primary care clinics 
in Baltimore, Detroit, New York City, 
and Portland, OR, from 2007–2008. 
Eligible physician, nurse practitioner, 
or physician assistant providers de-
livered primary care to HIV-infected 
patients. Providers completed base-
line assessments and a brief after-
visit questionnaire following each 
patient encounter. Participating pro-
viders completed informed consent 
and were provided with $250 at the 
end of the study. 
Patients were eligible if they were 
HIV-infected, 19 years of age or older, 
had at least one primary care visit 
in the last year, and spoke English. 
Trained study personnel enrolled 
patients from the waiting room of 
participating clinics and conducted 
in-person interviews following the of-
fice visit. Participating patients com-
pleted informed consent and were 
provided with $50 at the end of the 
study. Research assistants abstract-
ed ARVs, CD4 count, and HIV-1 
RNA viral load from patient medical 
records. Institutional Review Boards 
at each facility approved the study.
Outcome Measure
Participants responded to one (pa-
tients) or two (provider) questions 
assessing their comfort discussing 
substance use. Patients responded to 
“How comfortable do you feel telling 
your HIV provider about using drugs 
or alcohol?” with responses ranging 
from not at all comfortable to very 
comfortable (scale 1–4). Providers 
responded to two similarly worded 
questions: “Using the scale below, in-
dicate your level of comfort discuss-
ing illicit drug use (alcohol use for 
second question) with patients” with 
responses again ranging from not at 
all comfortable to very comfortable 
(scale 1–5). Patient and provider 
comfort variables were dichotomized 
into a “high comfort” group consist-
ing of individuals reporting the high-
est level of comfort for both alcohol 
and drugs and a “less than high com-
fort” group consisting of all other re-




graphic characteristics included 
self-reported patient gender, race/eth-
nicity (white, Black, Hispanic, Oth-
er), age (years), employment status 
(yes/no), and educational attainment 
(≥ high school degree/GED). Other 
patient-related covariates includ-
ed depression score on the 10-item 
Center for Epidemiologic Studies 
scale (CESD) (tertiles),21 patient ac-
tivation (tertiles),22 and communica-
tion self-efficacy from the four-item 
communication subscale of the HIV 
Self-Efficacy Questionnaire.23 High 
communication self-efficacy was de-
fined as a mean score of 10 versus 
<10, based on score distribution. 
Current problematic alcohol use 
was defined as at least one episode of 
drinking to intoxication in the past 
30 days using items from the Ad-
diction Severity Index-lite (ASI).24,25 
Current drug use was defined as 
any use of heroin, cocaine, amphet-
amines, marijuana, or methadone 
without a prescription in the past 
30 days using the ASI-lite. 
Patient-reported duration of the 
patient-provider relationship was 
categorized as less than or greater 
than 5 years in duration. The length 
of the patient-provider encounter in 
minutes was obtained from audio-
recordings. Each provider respond-
ed to the question “How would you 
describe your schedule today?” with 
responses ranging from “much bus-
ier than usual” to “slow” after each 
patient visit. The final variable was 
dichotomized into very busy versus 
less than very busy.
Provider Characteristics. Pro-
vider characteristics included self-
reported gender, age, race/ethnicity 
(white/non-white), type of training 
(physician/midlevel provider), time 
spent caring for HIV-infected pa-
tients (greater or less than 20 hours 
per week), and any history of com-
munication training (yes/no). Provid-
er self-reported stress was assessed 
over the past month using a four-
item instrument, dichotomized as 
highest stress tertile versus less 
than highest stress tertiles.26 Phy-
sician busyness was assessed using 
the question “How would you de-
scribe your schedule today?” with 
responses ranging from “much bus-
ier than usual” to “slow” after each 
patient visit. The final variable was 
dichotomized into very busy versus 
less than very busy. The role of pro-
vider confidence on the impact of dis-
cussions on substance was assessed 
by asking, “How confident are you 
that discussing substance use/abuse 
with your patients will make a dif-
ference in their future behavior?” 
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with responses dichotomized as very 
confident versus less than very con-
fident. 
Provider’s Practice Characteris-
tics. For each provider we estimated 
the characteristics of that practice by 
calculating the proportion of the pro-
vider’s patients in the study for each 
characteristic (eg, the proportion of 
each provider’s patients that were 
female, non-white, etc). We also cal-
culated the proportion of office visits 
greater than or equal to the median 
length for each provider. These vari-
ables were scaled for ease of inter-
pretation in final models to reflect 
the odds for a 10% change in pro-
portion. 
Analysis. We used descriptive sta-
tistics to report patient and provid-
er characteristics by comfort level 
(high/less than high). Bivariate as-
sociations between independent 
variables and comfort were estimat-
ed using c2 analysis for categorical 
variables and two-sided t tests for 
continuous. The provider bivariate 
analysis utilized Fisher’s exact test 
for cases where the expected cell 
count was less than five. 
Multivariable model development 
started with a base model investi-
gating the relationship of each inde-
pendent variable to patient comfort 
while controlling for site and pro-
vider clustering alone (base model, 
column 1, Table 2). Then variables 
identified from bivariate analy-
sis with a statistical significance of 
P≤.20 and those identified based on 
a priori hypotheses were added. This 
created a full model from which like-
lihood ratio and Hosmer-Lemeshow 
goodness of fit tests were utilized 
to assess the relative importance of 
each variable in the model to create 
a final model.27 Conceptually impor-
tant variables were reintroduced into 
the final model regardless of likeli-
hood ratio testing. In all multivari-
able models, site was included as 
a fixed effect variable to adjust for 
potential geographic clinical differ-
ences. Patient comfort models were 
adjusted for clustering by provider 
using generalized estimation equa-
tions. All analyses were conducted on 
STATA (version 11.0, October 2009, 
StataCorp, College Station, TX). 
Results
Participants. From 2006–2007, 
study personnel contacted 47 of 55 
eligible providers with 45 agreeing 
to participate (meeting recruitment 
goals) and two refusing. Study per-
sonnel identified 617 eligible pa-
tients during clinic visits occurring. 
Provider discretion excluded 18 pos-
sible participants due to feeling too 
rushed (n=12), the patient was too 
sick (n=5), or the visit was only for 
return of lab values (n=1). Of ap-
proached subjects (599), 434 con-
sented to participate and completed 
the study (72%). The most common 
reason for refusal to participate was 
lack of time to complete the inter-
view (106 individuals). 
For the current analysis, 21 addi-
tional patients were excluded: 17 for 
missing or incomplete audio-record-
ings, three for missing all substance 
use data, and one for missing demo-
graphic data, leaving a final analytic 
sample of 413 encounters. Addition-
ally, one provider was excluded from 
the provider analysis as they only 
had a single patient participate in 
the study (final provider n=44). 
The patient study sample was 
mostly male (65%), African American 
(59%), with a mean age of 45 years 
(standard deviation [SD]= 9.3, range 
20–77 years) (Table 1). The major-
ity were on antiretroviral therapy 
(77%) with their last CD4 count > 
200 (80%). Current illicit drug use 
was reported by 27% of patients 
(predominantly marijuana use), with 
9.5% reporting current problematic 
alcohol use. One third did not com-
plete high school or obtain an equiv-
alent degree. 
Providers were evenly split by 
gender (57% female) with a major-
ity of white race/ethnicity (68%) and 
a mean age of 44 years (SD=8.6) (Ta-
ble 3). Three quarters of the provid-
ers were physicians. 
The majority of patients (76%) 
and providers (73%) reported high 
comfort discussing substance use. 
Associations With High Patient 
Comfort Discussing Substance 
Issues. In unadjusted analysis (Ta-
ble 1), only 56% of current problem-
atic drinkers reported high comfort 
compared to 78% of non-problemat-
ic or non-drinkers (X2, P=.003). Two 
thirds of patients with current drug 
use reported high comfort compared 
to 79% of patients without current 
drug use (X2, P=.005). Among pa-
tients reporting less than high com-
fort, 38% had used drugs in the past 
month, and 17% had consumed alco-
hol to intoxication in the past month.
Patients with high communica-
tion self-efficacy or high patient ac-
tivation were more likely to report 
high comfort. Being on ARVs was 
strongly associated with high com-
fort, with 80% reporting high com-
fort compared to 65% of patients not 
on ARVs (X2, P=.003). Patients with 
greater depression symptoms were 
less likely to report high comfort (X2, 
P=.010). No provider characteristics 
were associated with high patient 
comfort discussing substance use.
In multivariable analysis (Table 
2), patients reporting current drug 
or problematic alcohol use had low-
er odds of endorsing high comfort 
(aOR=0.46, 95% CI=0.28–0.77 for 
drug use, aOR=0.32, CI=0.15–0.66, 
for alcohol use) after adjusting for 
demographics, education, self-efficacy, 
patient activation, depression, ARV 
status, site, and clustering by pro-
vider. A patient on ARVs had twice 
the odds of reporting high comfort 
compared to a patient not on ARVs 
(aOR=2.15, 95% CI=1.18–3.40). Pa-
tients who did not graduate high 
school were half as likely to report 
high comfort compared to graduates 
(aOR=0.45, 95% CI=0.22–0.93). Fe-
male patients were twice as likely to 
report high comfort (aOR=2.05, 95% 
CI=1.13–3.72). 
High patient activation was as-
sociated with increased odds of re-
porting high comfort (aOR=2.66, 95% 
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Table 1: Patient Participant Descriptors and Bivariate Associations With 
High Patient Comfort Discussing Substance Use*
Overall 
n (%) or 
Mean (SD)
Range
  Patient Comfort
c2 or 
t test  
P Value
Less Than High 
n (% or SD)
High Comfort 
n (% or SD)
Overall 413 (100) 100 (24) 313 (76) —
Patient characteristics


















Mean age (years) (range: 20–77) 45 (9) 45 (9) 46 (10) .488
High school diploma/GED or above 294 (71) 77 (77) 217 (70) .152
Currently employed 105 (25) 24(24) 81 (26) .695















On antiretroviral therapy 314(78) 63 (66) 251 (81) .003
CD4 count ≥200 318 (80) 73 (79) 245 (80) .880
Current problematic alcohol use 39 (10) 17 (17) 22 (7) .003
Any current drug use 112 (27) 38 (38) 74 (24) .005

























High physician busyness 141 (36) 33 (35) 108 (36) .875
Substance use discussed at visit 164 (40) 41 (41) 123 (39) .762
Mean visit length in minutes 24 (12) 27 (13.5) 23 (11.2) .009
Provider characteristics









Mean age of provider 44 (8.2) 45 (8.2) 44 (8.2) .413
Physician







>20 hours per week caring for HIV patients 198 (48) 53 (53) 145 (46) .245
High physician stress 120 (29) 30 (30) 90 (29) .811
History of communication training 276 (69) 59 (59) 217 (69) .056
High confidence in prevention conversations 93 (23) 20 (20) 73 (23) .489
High provider comfort discussing substance use 297 (72) 74 (74) 223 (71) .594
* P values for categorical variables calculated using chi-squared tests, while two-sided t test was utilized for continuous variables
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OR (95% CI) P Value
Final Model 







































On antiretroviral therapy (Reference=no) 2.15 (1.36–3.40) .001 2.33 (1.18–4.6) .015
Current problematic alcohol use (Reference=no) 0.32 (0.15–0.66) .002 0.33 (0.15–0.72) .006
Current drug use (Reference=no) 0.46 (0.28–0.77) .003 0.52 (0.29–0.93) .028
High communication













Length of visit 


































*Multivariable Model A reports the odds of high comfort for each independent variable while controlling for site and provider clustering. The Final 
Model includes all variables, as well as site and adjustment for provider clustering.
CI=1.24–5.69). Also, each 10-min-
ute increase in the length of the 
patient’s office visit was associated 
with nearly a quarter decrease in the 
odds of high comfort (aOR=0.78, 95% 
CI=0.64–0.99). 
A sensitivity analysis limiting 
the multivariable analysis to only 
those with current drug or alcohol 
use yielded similar results, though 
there was insufficient power to de-
tect a difference in self-efficacy or pa-
tient activation due to the smaller 
sample size.
Associations With High Provider 
Comfort Discussing Substance 
Use. In unadjusted analyses, provid-
ers with high comfort were younger 
(40 versus 46 years, 2-sided t test, 
P=.025). All midlevel providers, com-
pared to 65% of physicians, report-
ed high comfort (Fischer’s exact test, 
114 FEBRUARY 2013 • VOL. 45, NO. 2 FAMILY MEDICINE
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P=.041). Providers with a greater 
proportion of patients with a high 
school degree (75% versus 62%, two-
sided t test P=.015) and those with 
fewer patients on ARV (74% versus 
85%, two-sided t test, P=.059) more 
frequently reported high comfort dis-
cussing patient substance use. 
In multivariable analyses (Table 
4), no provider characteristics were 
associated with provider comfort. 
However, as a provider’s propor-
tion of patients on ARV increased, 
the odds of a provider reporting 
high comfort discussing substance 
use decreased (aOR: 0.38, 95% CI: 
0.15 -- 0.97). As the proportion of pa-
tients in the highest patient activa-
tion tertile increased, so did the odds 
of a provider reporting high comfort 
discussing substance use (aOR 2.87, 
95% CI: 1.01-8.14). 
Discussion
Patients and their providers must 
have the freedom to openly discuss 
substance use issues in primary care. 
There is scant research on factors in-
fluencing patients’ decisions to dis-
cuss drug or alcohol use with their 
Table 3: Provider Sample Descriptors and Bivariate Associations With High Provider Comfort Discussing Substance Use 
n (%) Provider Comfort P Value
Less Than High 
Comfort Discussing 
Substance Use With 
Patients 
n (% or SD)
High Comfort 
Discussing Substance 
Use With Patients 
n (% or SD)
Overall 44 (100) 12 (27) 32(73) —
Provider characteristics









Mean age of provider (range 30–64) 44 (8.6) 40 (6.6) 46 (8.7) 0.032
Physician







>20 hours/week caring for HIV patients 18 (41) 3 (25) 15 (47) 0.303**
High stress 12 (27) 5 (42) 7 (22) 0.189
High physician busyness 21 (49) 4 (33) 17 (55) 0.310**
History of communication training 28 (64) 7 (58) 21 (66) 0.654
High confidence in prevention conversation 9 (20) 1 (8) 8 (25) 0.405**
Practice characteristics
(Proportions of patients) Mean (SD)
Female patients 0.363 (0.19) 0.36 (0.2) 0.37 (0.2) 0.900
Non-white patients 0.769 (0.20) 0.74 (0.19) 0.78 (0.21) 0.546
Age ≥ 45 years 0.55 (0.22) 0.56 (0.19) 0.55 (0.23) 0.925
High school degree 0.72 (0.17) 0.62 (0.17) 0.75 (0.15) 0.015
Currently full- or part-time employed 0.25 (0.16) 0.20 (0.18) 0.27 (0.15) 0.228
Highest depression tertile 0.31 (0.14) 0.32 (0.16) 0.30 (0.14) 0.707
On anti-retrovirals 0.77 (0.18) 0.85 (0.17) 0.74 (0.17) 0.059
CD4 count <200 0.20 (0.12) 0.24 (0.12) 0.19 (0.12) 0.188
Current problematic alcohol use 0.09 (0.13) 0.12 (0.11) 0.08 (0.13) 0.386
Current drug use 0.26 (0.17) 0.27 (0.16) 0.26 (0.18) 0.864
High communication self-efficacy 0.61 (0.19) 0.58 (0.16) 0.62 (0.20) 0.583
Highest tertile of patient activation 0.31 (0.16) 0.25 (0.18) 0.33 (0.15) 0.184
Patients reporting knowing provider ≥ 5 years 0.33 (0.27) 0.23 (0.22) 0.37 (0.27) 0.129
Patients with a visit length >22 minutes (the 
median length)
0.49 (.32) 0.55 (0.36) 0.47 (0.31) 0.489
High patient comfort 0.78 (0.17) 0.77 (0.12) 0.77 (0.19) 0.857
P values for categorical variables calculated using chi-squared test (except (**) as Fischer’s Exact Test for low expected cell value was used) and a 
two-sided t test was utilized for continuous variables. 
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provider and little on providers’ com-
fort with substance use discussions. 
The current study demonstrates 
that, though self-reported comfort is 
high for both patients and providers, 
those most likely to benefit are least 
likely to be comfortable discussing 
substance use. 
Patients reporting higher levels 
of communication self-efficacy, anti-
retroviral use, and patient activation 
reported greater comfort, suggesting 
that interventions to improve com-
munication and self-management 
skills might increase patient com-
fort discussing substance use in HIV 
primary care settings. Patients with 
current illicit drug or problematic al-
cohol use were independently less 
likely to report high comfort discuss-
ing with their provider. 
Patient Comfort. Patients most 
likely to benefit from a discussion 
of their substance use were the 
least likely to report high comfort 
doing so. This is particularly im-
portant because patients who dis-
cuss substance use issues with their 
providers are more likely to receive 
treatment, yet this occurs in only a 
minority of primary care visits.2,7 
Several potentially modifiable 
patient characteristics were inde-
pendently associated with high pa-
tient comfort, suggesting potential 
targets for improving comfort. Pa-
tients with high communication self-
efficacy, those receiving ARV, and 
those with high patient activation 
more frequently reported high com-
fort. Communication self-efficacy has 
been previously associated with high 
education level and younger age, yet 
interventions have shown improved 
self-efficacy across diverse groups 
primarily in participation in medical 
care.28,29 Patient-directed interven-
tions to improve patient commu-
nication self-efficacy may facilitate 
comfort in communicating about 
substance use with their providers. 
Patient activation is defined as the 
knowledge, skill, and confidence an 
individual has in managing his or 
her disease.22 Patients with higher 
levels of activation exhibit more opti-
mal health behaviors and experience 
improved outcomes for patients with 
chronic illness such as diabetes and 
heart disease.30,31 Patients reporting 
higher levels of patient activation in 
the current study had greater than a 
threefold increase in odds of report-
ing high comfort. Likewise, the only 
provider characteristic independent-
ly associated with provider comfort 
discussing substance use issues with 
their patients was the proportion of 
their patients with high patient ac-
tivation, suggesting that greater ac-
tivation may facilitate substance use 
dialogue for both patients and pro-
viders. Interventions that improve 
patient activation may increase pa-
tient and provider comfort discuss-
ing substance use.
Other patient characteristics in-
dependently associated with high 
comfort included female gender, re-
ceipt of ARV, and higher educational 
level. Patients without a high school 
diploma or GED were half as likely 
to report high comfort compared to 
someone with a high school diploma 
or higher, even after accounting for 
current substance use, depression, 
and demographics. The strong asso-
ciation between less educational at-
tainment and decreased odds of high 
Table 4: Multivariable Associations of High Provider Comfort
Correlates Crude OR
Base Model Bivariate 
Associations 






















Mean age of provider 1.10 (1.00–1.21) 1.10 (1.00–1.22) 1.08 (0.94–1.23) .290
Highest stress group 0.39 (0.09–1.62) 0.39 (0.09–1.68) 0.40 (0.04–3.70) .418
Practice characteristics
(10% change in Proportion**)
Female patients 1.02 (0.72–1.45) 1.05 (0.70–1.56) 1.60 (0.87–2.96) .130
Non-white patients 1.11 (0.80–1.53) 1.15 (0.78–1.68) 1.79 (0.86–3.76) .121
Patients with a high school degree 1.75 (1.08–2.84) 1.96 (1.09–3.54) 2.40 (0.96–5.97) .061
Patients on ARV 0.67 (0.43–1.03) 0.67 (.43–1.04) 0.38 (0.15–0.97) .043
Patients in the highest tertile PAM 1.35 (0.87–2.11) 1.40 (0.86–2.26) 2.86 (1.01–8.14) .048
* Final model includes all correlates and controls for site.  
** Odds ratios reflect a change in 10% of the proportion of patients with a given characteristic. 
ARV—antiretroviral 
PAM— Patient Activation Measure
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comfort likely captures the greater 
health disparities experienced by 
individuals of lower socioeconomic 
status.32
Also, this study observed an in-
verse relationship between visit 
length and patient comfort. Longer 
visits may be required to address the 
competing medical and social needs 
of a more complex patient (ie, worse 
HIV-related health, lower health lit-
eracy, or active drug use),which take 
priority over addressing potentially 
uncomfortable discussions of sub-
stance use. Yet length of patient-
provider dialogue was shorter for 
patients with current and former un-
healthy alcohol use compared with 
non-drinkers in one recent study and 
comparable for those with illicit drug 
use versus non-user.20 Patients with 
long visits may be addressing oth-
er issues associated with discomfort 
talking about substance use (eg, 
medication adherence).
Provider Comfort. This study ob-
served an inverse association be-
tween the proportion of patients on 
ARV that a provider sees and the 
provider’s comfort discussing sub-
stance use. 
Also, this study observed a pos-
itive association between the pro-
portion of patients with the highest 
level of patient activation and pro-
vider comfort. Intuitively, a provider 
who sees a majority of patients who 
are highly activated or on ARV may 
feel more comfortable as their pa-
tients may be more engaged in their 
care or providers perceive their pa-
tients to have the skill set to try and 
make changes in their substance 
use. 
Provider comfort discussing sub-
stance use is a novel research ques-
tion without previous research on 
this specific topic. Related literature 
comes from patient-reported scor-
ing of provider performance in the 
realms o f  general  and HIV-
specific communication.33-35 From 
Roter and Hall’s systematic review 
of gender and patient-centered com-
munication, one would hypothesize 
that female providers would report 
greater comfort discussing substance 
use.34 This is consistent with work 
from the patient perspective. In Wil-
son and Kaplan, patient-rated com-
munication skills were higher for 
female providers.35 However, the 
current study did not observe any 
independent association between 
provider gender and comfort. 
Strengths and Limitations. As 
the largest study to date on patient 
or provider comfort discussing sub-
stance use, these findings inform fu-
ture research by identifying patient 
and provider characteristics associ-
ated with comfort. These findings 
should be interpreted in light of sev-
eral important limitations. First, the 
relatively small number of providers 
limits power to detect independent 
associations between provider char-
acteristics and provider comfort as 
ECHO was powered to detect differ-
ences in patient-level characteristics. 
Using provider-level data, however, 
provides a unique insight that has 
often been overlooked in the liter-
ature. Second, the cross-sectional 
study design limits causal inferences 
between participant characteristics 
and their comfort. Prospective, con-
trolled studies would help strength-
en causal inference. Finally, the 28% 
of nonparticipants may have differed 
in activation or comfort from partic-
ipants but overall our participation 
rate is in line with previous work in 
similar populations.36,37  
Conclusions
Connecting patients to drug or al-
cohol treatment often falls in the 
hands of primary care providers. 
This research identifies important 
correlates of patient and provider 
comfort that can inform future inter-
ventions to encourage medical pro-
viders to discuss substance use with 
their patients. Patients with current 
alcohol and drug use, in particular, 
reported little comfort discussing 
their use with their providers. Ef-
forts to improve the patient-physi-
cian dyad in terms of comfort having 
substance use discussions may im-
prove referral of patients to the 
treatment they need. 
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